Vancomycin Hydrochloride
NDC Package 72132-0290-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vancomycin Hydrochloride is a . Marketed by Avara Liscate Pharmaceuticals Services Spa, this product is identified by NDC 72132-0290 and is authorized under FDA application ANDA062912.

Identification & Billing

NDC Package Code
72132-0290-1
Package Description
10 VIAL in 1 CARTON / 1 mL in 1 VIAL
Product Code
72132-0290
11-Digit Billing Format
72132029001

Clinical Specifications

Proprietary Name
Vancomycin Hydrochloride
Dosage Form
-

Regulatory & Marketing

Labeler Name
Avara Liscate Pharmaceuticals Services Spa
FDA Application #
ANDA062912
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-20-2013
End Marketing Date
09-30-2025
Listing Expiration
09-30-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72132-0290-1 identifies a specific commercial package of 10 vial in 1 carton / 1 ml in 1 vial of Vancomycin Hydrochloride, labeled by Avara Liscate Pharmaceuticals Services Spa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Avara Liscate Pharmaceuticals Services Spa on February 20, 2013. The current certification is valid through September 30, 2025.

How is this Avara Liscate Pharmaceuticals Services Spa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72132029001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72132-0290-1
11-Digit CMS (5-4-2)
72132-0290-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.